The role of gut microbiota in bone homeostasis
Jie Li,Tung Percy Ho,Chaoran Liu,Simon Kwoon-Ho Chow,Margaret Ip,Jun Yu,Hei Sunny Wong,Wing-Hoi Cheung,Joseph Jao Yiu Sung,Ronald Man Yeung Wong,Wing Tung Percy Ho
DOI: https://doi.org/10.1302/2046-3758.101.bjr-2020-0273.r1
IF: 4.41
2021-01-01
Bone and Joint Research
Abstract:Aims The effect of the gut microbiota (GM) and its metabolite on bone health is termed the gut-bone axis. Multiple studies have elucidated the mechanisms but findings vary greatly. A systematic review was performed to analyze current animal models and explore the effect of GM on bone. Methods Literature search was performed on PubMed and Embase databases. Information on the types and strains of animals, induction of osteoporosis, intervention strategies, determination of GM, assessment on bone mineral density (BMD) and bone quality, and key findings were extracted. Results A total of 30 studies were included, of which six studies used rats and 24 studies used mice. Osteoporosis or bone loss was induced in 14 studies. Interventions included ten with probiotics, three with prebiotics, nine with antibiotics, two with short-chain fatty acid (SCFA), six with vitamins and proteins, two with traditional Chinese medicine (TCM), and one with neuropeptide Y1R antagonist. In general, probiotics, prebiotics, nutritional interventions, and TCM were found to reverse the GM dysbiosis and rescue bone loss. Conclusion Despite the positive therapeutic effect of probiotics, prebiotics, and nutritional or pharmaceutical interventions on osteoporosis, there is still a critical knowledge gap regarding the role of GM in rescuing bone loss and its related pathways. Cite this article: Bone Joint Res 2021;10(1):51–59.
orthopedics,cell & tissue engineering